TY - JOUR T1 - PRognostic information from sentinel lymph node biopsy in patients with thick melanoma AU - Scoggins CR, Bowen AL, Martin RC, II, et al Y1 - 2010/07/01 N1 - 10.1001/archsurg.2010.115 JO - Archives of Surgery SP - 622 EP - 627 VL - 145 IS - 7 N2 - Hypothesis  Sentinel lymph node (SLN) biopsy provides valuable prognostic information for patients with thick (T4) melanoma.Design  Post hoc analysis of data from a prospective, randomized trial.Setting  Academic and private hospitals.Patients  Data of 240 patients with melanoma thicker than 4 mm were analyzed. Patients with tumor-positive SLNs underwent completion lymphadenectomy. Disease-free and overall survival were evaluated by Kaplan-Meier analysis. Univariate and multivariate analyses were performed to evaluate factors predictive of tumor-positive SLNs and disease-free and overall survival.Results  Median thickness of melanoma was 5.6 mm, and patients were followed up for a median of 50 months. The SLNs were tumor positive in 100 patients (41.7%); 18% of these had additional positive nodes on completion lymphadenectomy. Extremity tumor location (risk ratio, 1.66; 95% confidence interval, 1.24-2.24; P = .001), Clark level (1.95; 1.33-2.87; P = .02), and lymphovascular invasion (1.57; 1.13-2.17; P = .01) were associated with a greater risk of tumor-positive SLNs. The patients with tumor-negative SLNs had significantly better median disease-free survival (46.5 vs 31.0 months; P = .04) and overall survival (55.5 vs 43.0 months; P = .004) compared with patients with tumor-positive SLNs. On multivariate analysis, male sex (risk ratio, 1.59; 95% confidence interval, 1.05-2.50; P = .02), increasing Breslow thickness (1.58; 1.10- 2.30; P = .03), ulceration (1.73; 1.18-2.59; P = .02), and tumor-positive SLNs (1.68; 1.17-2.43; P = .009) were associated with worse overall survival.Conclusion  The SLN biopsy provides useful prognostic information for patients with T4 melanoma. SN - 0004-0010 M3 - doi: 10.1001/archsurg.2010.115 UR - http://dx.doi.org/10.1001/archsurg.2010.115 ER -